LNSR vs REG · rev $29.9M vs P/E 34, rev $1.45B
LENSAR Inc (LNSR) versus Regency Centers Corporation (REG) — a side-by-side from cached financials, not a winner call.
LENSAR Inc (LNSR) is a medical devices company listed on US.
Regency Centers Corporation (REG) is a reit - retail company listed on US.
Latest reported LNSR revenue for 2026-06-30 was $29.9M. Net income was $39.9M. LNSR currently screens at market cap $156.7M.
Latest reported REG revenue for 2024-12-31 was $1.45B. Net income was $409.8M. Revenue was up 9.9% from 2023-12-31 to 2024-12-31. REG currently screens at market cap $12.93B and trailing P/E 33.5.
LNSR currently screens at market cap $156.7M. REG currently screens at market cap $12.93B and trailing P/E 33.5.
Not investment advice. Open the LNSR and REG stock pages for the full models.
Not investment advice.